Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of gadopiclenol-enhanced multiparametric MRI in breast cancer
2025-521810-24-00Phase 4Completed
- Sponsor
- Fundación Ribera Salud
- Start
- Sep 2025
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of gadopiclenol in breast cancer, sponsored by Fundación Ribera Salud. Started Sep 2025; status: completed.
02
Drugs
gadopiclenol
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2025-521810-24-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-521810-24-00.